Effect of Rifampin on Bosutinib When Both Are Given to Healthy People

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Study to examine whether rifampin has an effect on the pharmacokinetics of bosutinib.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Rifampin

Criteria

Inclusion Criteria:

• Healthy men age 18-50

• Healthy women of nonchildbearing potential, age 18-50